Acrospire Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Acrospire Investment Management’s Portfolio LCTX Stock Details LCTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell
2017 Q1	$12K	Sell
2016 Q4	$21K	Buy